DHA 'fish oil' supplements do not seem to slow cognitive, functional decline in Alzheimer's disease

Patients with mild to moderate Alzheimer's disease (AD) who received supplementation with the omega-3 fatty acid docosahexaenoic acid, believed to possibly reduce the risk of AD, did not experience a reduction in the rate of cognitive and functional decline, compared to patients who received placebo, according to a new study.

Read the whole article on Science Daily

More from Science Daily